PIGS, DOGS, BABOONS, AND MAN - LESSONS FOR STENTING FROM ANIMAL STUDIES

被引:32
作者
SCHWSARTZ, RS
HOLMES, DR
机构
[1] Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota
关键词
D O I
10.1111/j.1540-8183.1994.tb00469.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A new era in interventional cardiology has arrived with the widespread use of intracoronary stents. These devices have not only markedly improved the safety of dilatation, but have also limited restenosis through achievement of a larger postprocedure lumen. Much work remains in furthering this technology, since two major limitations are thrombosis and neointimal hyperplasia that still cause restenosis. Stent placement in animals provides insight into both of these areas. The volume of neointima is directly proportional to the depth of injury induced by the stent in at least three species: the pig, baboon, and dog. Across each species, a numerically different slope exists for the injury-neointimal thickness regression. Treatments to limit hyperplasia within a species do not change this slope, but instead alter the y-intercept. Stent thrombosis in animal models consists principally of platelet-rich thrombi. The time course of thrombus appears to differ across pigs and baboons. Antiplatelet agents limit, but do not eliminate the problem in animals, suggesting that newer and more potent antiplatelet agents may improve stent thrombosis in clinical trials. The future of stent technology lies in developing an antithrombotic device that also eliminates neointimal hyperplasia. Intense studies of animal models and improved understanding of their pathophysiology will facilitate this progress.
引用
收藏
页码:355 / 368
页数:14
相关论文
共 39 条
[1]  
Frank G, Sigwart U, Coronary stents and restenosis: Potential solution for a vexing problem, Coronary Restenosis, pp. 325-343, (1992)
[2]  
Goy JJ, Sigwart U, Vogt P, Et al., Long‐term follow‐up of the first 56 patients treated with intracoronary self‐expanding stents (the Lausanne experience), Am J Cardiol, 67, pp. 569-572, (1991)
[3]  
Sigwart U, Puel J, Mirkovitch V, Et al., Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty, N Engl J Med, 316, pp. 701-706, (1987)
[4]  
Bairn DS, Levine MJ, Leon MB, Et al., Management of restenosis within the Palmaz‐Schatz coronary stent (the U.S. multi‐center experience). The U.S. Palmaz‐Schatz Stent Investigators, Am J Cardiol, 71, pp. 364-366, (1993)
[5]  
Colombo A, Maiello L, Almagor Y, Et al., Coronary stenting: Single institution experience with the initial 100 cases using the Palmaz‐Schatz stent, Cathet Cardiovasc Diagn, 26, pp. 171-176, (1992)
[6]  
Haude M, Erbel R, Straub U, Et al., Coronary stent implantation in acute vessel closure 48 hours after an unsatisfactory coronary angioplasty, Cathet Cardiovasc Diagn, 21, pp. 263-265, (1990)
[7]  
Schatz RA, Goldberg S, Leon M, Et al., Clinical experience with the Palmaz‐Schatz coronary stent, Journal of the American College of Cardiology, 17, pp. 155B-159B, (1991)
[8]  
Kuntz RE, Gibson CM, Nobuyoshi M, Et al., Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy, JACC, 21, pp. 15-25, (1993)
[9]  
Schwartz RS, Murphy JG, Edwards WD, Et al., Restenosis after balloon angioplasty: A practical proliferative model in porcine coronary arteries, Circulation, 82, pp. 2190-2200, (1990)
[10]  
Santoian EC, King SB, Intravascular stents, intimal proliferation and restenosis, JACC, 19, pp. 877-879, (1992)